These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37963701)
1. Hanumunthadu B; Kanji N; Owino N; Ferreira Da Silva C; Robinson H; White R; Ferruzzi P; Nakakana U; Canals R; Pollard AJ; Ramasamy M; BMJ Open; 2023 Nov; 13(11):e072938. PubMed ID: 37963701 [TBL] [Abstract][Full Text] [Related]
2. Nontyphoidal salmonella disease: Current status of vaccine research and development. Tennant SM; MacLennan CA; Simon R; Martin LB; Khan MI Vaccine; 2016 Jun; 34(26):2907-2910. PubMed ID: 27032517 [TBL] [Abstract][Full Text] [Related]
3. Protocol for the challenge non-typhoidal Smith C; Smith E; Rydlova A; Varro R; Hinton JCD; Gordon MA; Choy RKM; Liu X; Pollard AJ; Chiu C; Cooke GS; Gibani MM BMJ Open; 2024 Jan; 14(1):e076477. PubMed ID: 38199617 [TBL] [Abstract][Full Text] [Related]
4. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653 [TBL] [Abstract][Full Text] [Related]
5. Vaccine value profile for invasive non-typhoidal Salmonella disease. Martin LB; Tack B; Marchello CS; Sikorski MJ; Owusu-Dabo E; Nyirenda T; Mogasale V; Crump JA Vaccine; 2024 Jul; 42(19S1):S101-S124. PubMed ID: 39003017 [TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis. Rossi O; Caboni M; Negrea A; Necchi F; Alfini R; Micoli F; Saul A; MacLennan CA; Rondini S; Gerke C Clin Vaccine Immunol; 2016 Apr; 23(4):304-14. PubMed ID: 26865597 [TBL] [Abstract][Full Text] [Related]
7. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella. De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
9. Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa. Bornstein K; Hungerford L; Hartley D; Sorkin JD; Tapia MD; Sow SO; Onwuchekwa U; Simon R; Tennant SM; Levine MM PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005283. PubMed ID: 28182657 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel trivalent invasive non-typhoidal Salmonella outer membrane vesicles based vaccine against salmonellosis and fowl typhoid in chickens. Maiti S; Halder P; Banerjee S; Dutta M; Kumar Mukhopadhyay A; Dutta S; Koley H Immunobiology; 2022 Mar; 227(2):152183. PubMed ID: 35121180 [TBL] [Abstract][Full Text] [Related]
12. Accelerating clinical development of a live attenuated vaccine against McCann N; Emary K; Singh N; Mclean F; Camara S; Jones E; Kim YC; Liu X; Greenland M; Conlin K; Hill J; Verheul M; Robinson H; Angus B; Ramasamy MN; Levine MM; Pollard AJ BMJ Open; 2023 May; 13(5):e068966. PubMed ID: 37225278 [TBL] [Abstract][Full Text] [Related]
13. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF mBio; 2018 Mar; 9(2):. PubMed ID: 29511082 [TBL] [Abstract][Full Text] [Related]
15. Non-typhoidal Salmonella serovars associated with invasive and non-invasive disease in the Lao People's Democratic Republic. Le Thi Phuong T; Rattanavong S; Vongsouvath M; Davong V; Phu Huong Lan N; Campbell JI; Darton TC; Thwaites GE; Newton PN; Dance DAB; Baker S Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):418-424. PubMed ID: 29342283 [TBL] [Abstract][Full Text] [Related]
16. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Anti-Bacterial Immunity against Systemic Infection by Fiorino F; Pettini E; Koeberling O; Ciabattini A; Pozzi G; Martin LB; Medaglini D Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065899 [No Abstract] [Full Text] [Related]